Bain, S., Davies, M., Charpentier, G., Flacke, F., Goyeau, H., Woloschak, M., . . . Edelman, S. (2019). A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes. Journal of Diabetes Science and Technology, p. 193229681882170. doi:10.1177/1932296818821706

Bain, Steve, Melanie Davies, Guillaume Charpentier, Frank Flacke, Harmonie Goyeau, Michael Woloschak, Christoph Hasslacher, Giacomo Vespasiani, and Steven Edelman. "A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes." Journal of Diabetes Science and Technology 2019: 193229681882170.

Bain, Steve, et al. "A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes." Journal of Diabetes Science and Technology 2019: 193229681882170.